BACE1 and Alzheimer disease: Our study further demonstrated that PA intervention effectively inhibited AD‐induced JNK phosphorylation, decreased BACE1 expression, mitigated Aβ aggregation, and attenuated neuroinflammatory responses (Figure 5).